Turing Pharmaceuticals pledged to cut the cost of its $750-per-pill HIV treatment drug Daraprim. However, it is instead only reducing charges to hospitals by up to 50 percent for the toxoplasmosis medication.
Turing Pharmaceuticals pledged to cut the cost of its $750-per-pill HIV treatment drug Daraprim. However, it is instead only reducing charges to hospitals by up to 50 percent for the toxoplasmosis medication.
Share this Article
Recommended